Open Heart

JUNE 2, 2022

Severe tricuspid regurgitation (TR) is an undertreated common pathology associated with significant morbidity and mortality. Classically, surgical repair or valve replacement were the only therapeutic options and are associated with up to 10% postprocedural mortality. Transcatheter tricuspid valve interventions are a novel and effective therapeutic option for the treatment of significant TR.

Tricuspid 52

Tricuspid 52

EMS 12-Lead

JUNE 1, 2022

David Didlake Firefighter / Paramedic Acute Care Nurse Practitioner @DidlakeDW Peer review provided by Dr. Steve Smith [link] @SmithECGblog A 72 y/o Male experiences a syncopal episode while seated. This occurred in a public place, so bystanders rushed to his aid and provided immediate assistance to protect against any associated fall or head strike.

Heart Failure 52

Heart Failure Myocardial Infarction Bradycardia Chest Pain 52

Dr. Smith's ECG Blog

JUNE 1, 2022

A 40-something male with no previous cardiac disease presented with chest pain. Here is his ECG: There is no clear evidence of OMI or ischemia. There is a tiny amount of STE in aVL, but it is NOT in the context of a tiny R-wave. There is a tiny amount of STD in lead III, with some non-specific T-wave flattening. I am glad that Ken Grauer (below) brings up the issue of whether the presence of "T-wave in V1 taller than T-wave in V6" is evidence for OMI.

Chest Pain 52

Chest Pain STEMI Myocardial Infarction Bradycardia 52

JAMA Cardiology

MAY 31, 2022

This cohort study conducted using nationwide registers assesses the risks of myocarditis and pericarditis after SARS-CoV-2 messenger RNA vaccinations in a combined population of 23.1 million individuals across Denmark, Finland, Norway, and Sweden.

Pericarditis 40

Pericarditis 40

Open Heart

JUNE 1, 2022

Objectives We aim to assess the association of cardiovascular medications with outcomes of patients referred to the diagnostic heart failure (HF) clinic with symptoms or signs of possible HF, raised N-terminal pro-brain-type natriuretic peptide (NT-proBNP) but no evidence of HF on transthoracic echocardiography (TTE). Methods Data were collected prospectively into the Sheffield HEArt Failure (SHEAF) registry between April 2012 and January 2020.

Heart Failure 52

Heart Failure Kidney Disease Atrial Fibrillation Hypertension 52

Dr. Prateek Bhatnagar

MAY 30, 2022

[link]

52

52

Open Heart

JUNE 1, 2022

Objectives To compare the shape and strength of the associations of resting heart rate (RHR) with incident heart failure (HF) and pulmonary heart disease (PHD) in Chinese adults. Methods The prospective China Kadoorie Biobank recruited >0.5 million adults from 10 geographically diverse regions (5 urban, 5 rural) of China during 2004–2008. After an 11-year follow-up, 6082 incident cases of HF and 5572 cases of PHD, were recorded among 491 785 participants with no prior history of heart

Heart Failure 52

Heart Failure Heart Disease Pulmonary Hypertension 52

Open Heart

MAY 31, 2022

Background Hepatocyte growth factor (HGF) is a biomarker with potential for use in the diagnosis, treatment and prognostication of cardiovascular disease (CVD). Elevated HGF is associated with calcification in the coronary arteries. However, knowledge is limited on the role HGF may play in extracoronary calcification (ECC). This study examined whether HGF is associated with ECC in the aortic valve (AVC), mitral annulus (MAC), ascending thoracic aorta and descending thoracic aortic (DTAC).

Atherosclerosis 52

Atherosclerosis Aortic valve Risk Factors Aortic 52

Open Heart

MAY 31, 2022

Aims This study aims to (1) define the characteristics of patients with a first admission for heart failure (HF), stratified by type (reduced (HFrEF) vs preserved (HFpEF) ejection fraction) in a regional Australian setting; (2) compare the outcomes in terms of mortality and rehospitalisation and (3) assess adherence to the treatment guidelines. Methods We identified all index hospitalisations with HF to John Hunter Hospital and Tamworth Rural Referral Hospital in the Hunter New England Local Hea

Heart Failure 52

Heart Failure Outcomes Echocardiogram Hospital 52

Open Heart

JUNE 1, 2022

Background There are limited data on structural heart disease among people living with HIV in southern Africa, where the success of antiretroviral therapy (ART) has drastically improved life expectancy and where risk factors for cardiovascular disease are prevalent. Methods We performed a cross-sectional study of screening echocardiography among adults (≥18 years) with HIV in Malawi presenting for routine ART care.

Blood Pressure 40

Blood Pressure Echocardiogram Risk Factors Heart Failure 40

Open Heart

MAY 31, 2022

Introduction Survival gaps in acute heart failure (AHF) continue to expand globally. Multinational heart failure (HF) registries have highlighted variations between countries. Whether discrepancies in HF practice and outcomes occur across different health systems (ie, private, public or universal healthcare) within a city or between countries remain unclear.

Heart Failure 40

Heart Failure Outcomes Blood Pressure Hospital 40

JAMA Cardiology

MAY 31, 2022

This meta-analysis of patients with out-of-hospital cardiac arrest assesses the long-term survival rate in those who survive the initial hospital stay.

Cardiac Arrest 40

Cardiac Arrest Hospital 40

Open Heart

JUNE 1, 2022

Aim Inflammatory cytokines in patients with rheumatoid arthritis (RA) directly affect cardiac electrophysiology by inhibiting cardiac potassium currents, leading to delay of cardiac repolarisation and QT-prolongation. This may result in lethal arrhythmias. We studied whether RA increases the rate of out-of-hospital cardiac arrest (OHCA) in the general population.

Cardiac Arrest 52

Cardiac Arrest Hospital Cardiovascular Disease Electrophysiology 52